WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MABLINK wurde als Wortmarke am 15.07.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1564321 |
| Länder | 
|
| Basismarke |
Nr. 4614472,
15. Januar 2020
|
| Anmeldedatum | 15. Juli 2020 |
| Ablaufdatum | 15. Juli 2030 |
Markeninhaber
14 rue Waldeck-Rousseau
F-69006 LYON
FR
F-69006 LYON
FR
Markenvertreter
235 cours Lafayette
F-69006 LYON
FR
Waren und Dienstleistungen
01
Chemical, biochemical, biological and biotechnological
preparations; chemical substances for the manufacture of
pharmaceutical products; chemical substances for tethering
molecules, in particular chemical substances for tethering
molecules for cancer therapy, for research in active
substances and medicines; chemical substances for the
formation of antibody conjugates; chemical reagents for
scientific purposes other than for medical or veterinary
purposes; reagents for scientific or medical research;
chemical, biochemical and biological reagents; chemicals
for bioconjugation, reversible cysteine protection, surface
modification, and the production of prodrugs; antibodies and
antibody conjugates for scientific purposes, other than for
medical or veterinary purposes; antibodies for scientific or
medical research; molecules and biomolecules, especially
reagents, antibody fragments, antibodies, all intended for
fundamental research and development, medical research and
scientific diagnosis; Diagnostic products for scientific or
research use related to conjugated antibodies (medicines)
05
Pharmaceutical preparations; pharmaceutical products, in
particular for the prevention or treatment of human
diseases; chemical, biological and biochemical products for
medical and pharmaceutical use, especially, antibody-drug
conjugates or any protein combined with a drug, a
polynucleotide, another protein, a chemical entity, or
another functional entity, or these products used as binders
or fillers; pharmaceutical preparations, in particular
bioconjugates, intended for the diagnosis and treatment of
diseases; antibody products, especially, antibody or protein
bioconjugates for the medical diagnosis and treatment of
diseases, including antibody/protein drug conjugates,
antibody/protein labeled conjugates and antibody/protein
imaging agent conjugates; delivery devices for antibodies;
molecules and biomolecules, especially, reagents, antibody
fragments, antibodies, all intended for medical diagnosis
and disease treatment; pharmaceutical products,
preparations and medical articles, especially antibodies,
antibody conjugates and active principles and antibody
conjugates; chemical reagents for medical use, in
particular chemical reagents to bind molecules for medical
use; chemical reagents for the functionalization of
biomolecules for medical use
40
Preparation, transformation, processing of biopharmaceutical
materials and especially reagents, antibodies and conjugated
antibodies; processing and transformation of
biopharmaceutical materials on behalf of third parties;
custom manufacturing of scientific, medical, chemical,
biochemical and pharmaceutical products
42
Scientific research; biological and chemical research;
biochemical research and development; research and
development in the pharmaceutical, biomedical and
biotechnological fields, especially research into
antibodies, including conjugated antibodies; research and
development in the fields of biological development and
biomanufacturing; laboratory research, analysis,
evaluation, development and clinical testing of therapeutic,
preventive and diagnostic compositions and treatments;
conducting scientific and medical research for third
parties; consultancy in the field of pharmaceutical
research, chemistry, biotechnology; custom synthesis of
chemical substances; chemical and/or biological development
services; services of a chemical and/or a biologist;
chemical and biological laboratory services; laboratory
services concerning the modification and production of
reagents, antibodies and conjugated antibodies; research
and development services in the field of reagent development
and production of antibodies and conjugated antibodies;
conducting chemical and/or biological analyses; customized
design and development of chemical reagents, antibodies and
conjugated antibodies; development of chemical substances,
in particular chemical substances to tether molecules and in
particular technological platforms in the form of or used
for the creation or improvement of antibody-drug conjugates
or any protein combined with a drug, a polynucleotide,
another protein, a chemical entity or another functional
entity intended for industry and science
44
Medical services; medical modification of antibodies;
medical services in the field of personalized medicine;
advice and information services with respect to
biopharmaceutical products; pharmaceutical advice;
consultancy services in the field of medicine
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 04. Juli 2022 | 2022/27 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 12. Mai 2022 | 2022/20 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 18. April 2022 | 2022/16 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. April 2022 | 2022/14 Gaz | CA | Ablehnung |
| 03. Januar 2022 | 2022/1 Gaz | KR | Ablehnung |
| 16. November 2021 | 2021/46 Gaz | BR | Ablehnung |
| 04. November 2021 | 2021/44 Gaz | JP | Ablehnung |
| 24. Juni 2021 | 2021/27 Gaz | RAW: Limitation | |
| 03. Mai 2021 | 2021/19 Gaz | IN | Ablehnung |
| 28. April 2021 | 2021/17 Gaz | EM | Ablehnung |
| 16. März 2021 | 2021/13 Gaz | CN | Ablehnung |
| 05. Januar 2021 | 2021/1 Gaz | US | Ablehnung |
| 15. Juli 2020 | 2020/48 Gaz | FR | Eintragung |
ID: 141564321